Abstract | AIMS: METHODS: RESULTS: From 440 patients initially randomized, outcome data were available in 432 (98.2%) patients at a median follow-up of 4.9 (interquartile range [IQR] 4.4-5.0) years. Thrombectomy was associated with a significant reduction of the combined endpoint compared to conventional PCI (19.9% vs. 30.7%, p = 0.01). This finding was primarily driven by a reduced rate of reinfarction with thrombectomy (3.4% vs. 10.3%, p = 0.01). Thrombectomy was still independently associated with the combined endpoint after multivariable adjustment (hazard ratio [HR] 0.47, 95% confidence interval [CI] 0.30-0.76, p = 0.002). Findings were consistent across all analyzed subgroups (p values for interaction all > 0.05). CONCLUSIONS: In NSTEMI, thrombus aspiration is associated with favorable clinical outcome during long-term follow-up. CLINICAL TRIAL REGISTRATION: NCT01612312.
|
Authors | Hans-Josef Feistritzer, Roza Meyer-Saraei, Christiane Lober, Michael Böhm, Bruno Scheller, Bernward Lauer, Tobias Geisler, Meinrad Gawaz, Leonhard Bruch, Norbert Klein, Uwe Zeymer, Ingo Eitel, Alexander Jobs, Anne Freund, Steffen Desch, Suzanne de Waha-Thiele, Holger Thiele |
Journal | Clinical research in cardiology : official journal of the German Cardiac Society
(Clin Res Cardiol)
Vol. 109
Issue 10
Pg. 1223-1231
(Oct 2020)
ISSN: 1861-0692 [Electronic] Germany |
PMID | 32030497
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Topics |
- Aged
- Coronary Thrombosis
(therapy)
- Female
- Follow-Up Studies
- Heart Failure
(epidemiology, etiology)
- Humans
- Male
- Middle Aged
- Non-ST Elevated Myocardial Infarction
(therapy)
- Percutaneous Coronary Intervention
(methods)
- Thrombectomy
(methods)
- Treatment Outcome
|